首页 > 最新文献

Clinical and Experimental Ophthalmology最新文献

英文 中文
Neonatal gut microbiota profile and the association with retinopathy of prematurity in preterm infants. 新生儿肠道微生物群谱及与早产儿视网膜病变的关系。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-25 DOI: 10.1111/ceo.14441
Yin-Hsi Chang, Yuan-Ming Yeh, Chien-Chung Lee, Cheng-Hsun Chiu, Hung-Chi Chen, Yi-Jen Hsueh, Chia-Wen Lee, Reyin Lien, Shih-Ming Chu, Ming-Chou Chiang, Eugene Yu-Chuan Kang, Kuan-Jen Chen, Nan-Kai Wang, Laura Liu, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu

Background: To explore the role of gut microbiota in preterm infants at high risk of developing retinopathy of prematurity (ROP).

Methods: Preterm infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1500 g born between 2020 and 2021 were prospectively enrolled. Their faecal samples were collected and analysed at different postnatal ages of life using 16S rRNA gene sequencing on the Miseq platform. The main outcome measures were the microbial diversity, taxonomy, relative abundance, bacterial predicted functional analysis, and their associations with different ROP groups. Subgroup analyses were performed by matching their GA and BW across different ROP groups.

Results: A total of 268 stool samples were collected from 110 preterm infants, including 13 with type 1 ROP, 44 with type 2 or mild ROP, and 53 without ROP. Type 1 ROP showed no significant difference in microbial diversity up to 8 postnatal weeks (p = 0.057), while type 2 and no ROP groups displayed increased diversity (p = 0.0015 and p = 0.049, respectively). Bifidobacterium genera was notably less abundant in type 1 ROP group at first postnatal week (p = 0.022) and remained low in subsequent weeks. Predicted functional analysis revealed enriched pathways in membrane transport, carbohydrate metabolism, amino acid metabolism, and replication and repair.

Conclusions: Reduced gut microbial diversity may be associated with ROP development in high-risk preterm infants. Further research is needed to comprehend how early-life Bifidobacterium reduction affects metabolism and how targeting microbiome may help for ROP prevention and management.

背景:探讨肠道微生物群在早产儿视网膜病变高风险人群中的作用:探讨肠道微生物群在早产儿视网膜病变(ROP)高风险人群中的作用:结果:110 名胎龄(GA)早产儿共采集了 268 份粪便样本:共收集了 110 名早产儿的 268 份粪便样本,其中 13 名患有 1 型早产儿视网膜病变,44 名患有 2 型或轻度早产儿视网膜病变,53 名未患有早产儿视网膜病变。1 型 ROP 在出生后 8 周内的微生物多样性无明显差异(p = 0.057),而 2 型和无 ROP 组的微生物多样性有所增加(分别为 p = 0.0015 和 p = 0.049)。在出生后第一周,1 型 ROP 组中双歧杆菌属的数量明显较少(p = 0.022),并且在随后的几周中仍然较少。预测功能分析显示,膜转运、碳水化合物代谢、氨基酸代谢以及复制和修复的途径丰富:结论:肠道微生物多样性的降低可能与高风险早产儿发生视网膜病变有关。结论:肠道微生物多样性的减少可能与高风险早产儿的视网膜病变有关。还需要进一步研究,以了解生命早期双歧杆菌的减少如何影响新陈代谢,以及针对微生物组的研究如何有助于视网膜病变的预防和管理。
{"title":"Neonatal gut microbiota profile and the association with retinopathy of prematurity in preterm infants.","authors":"Yin-Hsi Chang, Yuan-Ming Yeh, Chien-Chung Lee, Cheng-Hsun Chiu, Hung-Chi Chen, Yi-Jen Hsueh, Chia-Wen Lee, Reyin Lien, Shih-Ming Chu, Ming-Chou Chiang, Eugene Yu-Chuan Kang, Kuan-Jen Chen, Nan-Kai Wang, Laura Liu, Yih-Shiou Hwang, Chi-Chun Lai, Wei-Chi Wu","doi":"10.1111/ceo.14441","DOIUrl":"https://doi.org/10.1111/ceo.14441","url":null,"abstract":"<p><strong>Background: </strong>To explore the role of gut microbiota in preterm infants at high risk of developing retinopathy of prematurity (ROP).</p><p><strong>Methods: </strong>Preterm infants with gestational age (GA) < 32 weeks and/or birth weight (BW) < 1500 g born between 2020 and 2021 were prospectively enrolled. Their faecal samples were collected and analysed at different postnatal ages of life using 16S rRNA gene sequencing on the Miseq platform. The main outcome measures were the microbial diversity, taxonomy, relative abundance, bacterial predicted functional analysis, and their associations with different ROP groups. Subgroup analyses were performed by matching their GA and BW across different ROP groups.</p><p><strong>Results: </strong>A total of 268 stool samples were collected from 110 preterm infants, including 13 with type 1 ROP, 44 with type 2 or mild ROP, and 53 without ROP. Type 1 ROP showed no significant difference in microbial diversity up to 8 postnatal weeks (p = 0.057), while type 2 and no ROP groups displayed increased diversity (p = 0.0015 and p = 0.049, respectively). Bifidobacterium genera was notably less abundant in type 1 ROP group at first postnatal week (p = 0.022) and remained low in subsequent weeks. Predicted functional analysis revealed enriched pathways in membrane transport, carbohydrate metabolism, amino acid metabolism, and replication and repair.</p><p><strong>Conclusions: </strong>Reduced gut microbial diversity may be associated with ROP development in high-risk preterm infants. Further research is needed to comprehend how early-life Bifidobacterium reduction affects metabolism and how targeting microbiome may help for ROP prevention and management.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta-analysis. 原发性玻璃体视网膜淋巴瘤患者各种治疗方法的比较:系统回顾与荟萃分析。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-24 DOI: 10.1111/ceo.14443
Michael Ostrovsky, Tal Corina Sela, Zohar Habot-Wilner

Background: This systematic review and meta-analysis investigated different treatment modalities' effect on the risk of central nervous system lymphoma progression, ocular disease relapse, systemic lymphoma development and overall survival in primary vitreoretinal lymphoma patients.

Methods: PubMed, EMBASE, Scopus and the Cochrane Library of clinical trials were searched from inception to April 21, 2024. Cohort, cross-sectional and case series studies were included. Methodological quality was assessed using the NIH quality assessment tools. Heterogeneity between studies was assessed using Chi square test and I2 statistic. Outcomes were pooled as odds ratios (OR) using fixed-effects models. Risk of publication bias was assessed using a funnel plot.

Results: Included were 28 studies with 476 participants. Ocular treatments included intravitreal methotrexate and/or rituximab injections and ocular radiotherapy. Systemic treatments included intravenous and/or intrathecal chemotherapy, whole-brain radiotherapy and autologous stem cell transplantation. Ocular treatment alone, as compared to systemic or combined treatment, resulted in significantly lower risk of central nervous system lymphoma development (OR = 0.54, p = 0.02) and in no significant difference in the risk for progression to systemic disease (OR = 0.38, p = 0.30) or in overall survival. Significantly lower risk of ocular relapse was found in patients receiving ocular or combined therapy as compared to systemic therapy alone (OR = 0.26, p = 0.001). A subgroup analysis, comparing ocular treatment alone and combined treatment, found no significant difference regarding the risk of central nervous system or systemic lymphoma progression, ocular disease relapse and overall survival.

Conclusions: No benefit was observed for the addition of systemic therapy to ocular treatment in patients with primary vitreoretinal lymphoma.

背景:本系统综述和荟萃分析研究了不同治疗方式对原发性玻璃体视网膜淋巴瘤患者中枢神经系统淋巴瘤进展、眼部疾病复发、全身淋巴瘤发展和总生存期风险的影响:方法:检索了 PubMed、EMBASE、Scopus 和 Cochrane Library 中从开始到 2024 年 4 月 21 日的临床试验。纳入了队列、横断面和病例系列研究。采用 NIH 质量评估工具对方法学质量进行评估。研究之间的异质性采用卡方检验和 I2 统计量进行评估。采用固定效应模型将结果汇总为几率比(OR)。采用漏斗图评估发表偏倚风险:结果:共纳入 28 项研究,476 名参与者。眼部治疗包括玻璃体内注射甲氨蝶呤和/或利妥昔单抗以及眼部放疗。全身治疗包括静脉注射和/或鞘内化疗、全脑放疗和自体干细胞移植。与全身治疗或联合治疗相比,单纯眼部治疗可显著降低中枢神经系统淋巴瘤的发病风险(OR = 0.54,p = 0.02),但在发展为全身性疾病的风险(OR = 0.38,p = 0.30)或总生存率方面没有显著差异。与单独接受系统治疗相比,接受眼部治疗或联合治疗的患者眼部复发风险明显降低(OR = 0.26,p = 0.001)。一项亚组分析比较了眼部单独治疗和联合治疗,发现在中枢神经系统或全身淋巴瘤进展风险、眼部疾病复发和总生存率方面没有显著差异:原发性玻璃体视网膜淋巴瘤患者在眼部治疗的基础上加用全身治疗,未发现任何益处。
{"title":"Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta-analysis.","authors":"Michael Ostrovsky, Tal Corina Sela, Zohar Habot-Wilner","doi":"10.1111/ceo.14443","DOIUrl":"https://doi.org/10.1111/ceo.14443","url":null,"abstract":"<p><strong>Background: </strong>This systematic review and meta-analysis investigated different treatment modalities' effect on the risk of central nervous system lymphoma progression, ocular disease relapse, systemic lymphoma development and overall survival in primary vitreoretinal lymphoma patients.</p><p><strong>Methods: </strong>PubMed, EMBASE, Scopus and the Cochrane Library of clinical trials were searched from inception to April 21, 2024. Cohort, cross-sectional and case series studies were included. Methodological quality was assessed using the NIH quality assessment tools. Heterogeneity between studies was assessed using Chi square test and I<sup>2</sup> statistic. Outcomes were pooled as odds ratios (OR) using fixed-effects models. Risk of publication bias was assessed using a funnel plot.</p><p><strong>Results: </strong>Included were 28 studies with 476 participants. Ocular treatments included intravitreal methotrexate and/or rituximab injections and ocular radiotherapy. Systemic treatments included intravenous and/or intrathecal chemotherapy, whole-brain radiotherapy and autologous stem cell transplantation. Ocular treatment alone, as compared to systemic or combined treatment, resulted in significantly lower risk of central nervous system lymphoma development (OR = 0.54, p = 0.02) and in no significant difference in the risk for progression to systemic disease (OR = 0.38, p = 0.30) or in overall survival. Significantly lower risk of ocular relapse was found in patients receiving ocular or combined therapy as compared to systemic therapy alone (OR = 0.26, p = 0.001). A subgroup analysis, comparing ocular treatment alone and combined treatment, found no significant difference regarding the risk of central nervous system or systemic lymphoma progression, ocular disease relapse and overall survival.</p><p><strong>Conclusions: </strong>No benefit was observed for the addition of systemic therapy to ocular treatment in patients with primary vitreoretinal lymphoma.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma. 医护人员对青光眼多基因风险检测的认识和态度。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-08 DOI: 10.1111/ceo.14438
Georgina L Hollitt, Miriam C Keane, Thi T Nguyen, Mark M Hassall, Owen M Siggs, Jamie E Craig, Emmanuelle Souzeau

Background: Effective clinical implementation of polygenic risk testing for glaucoma relies on healthcare professionals' attitudes and knowledge of the test. Given the emerging applications of the test, it will likely impact a range of healthcare professionals and will require competency in polygenic risk scores concepts for all those involved in patient care. To our knowledge, this is the first study to assess healthcare professionals' views towards polygenic testing for glaucoma.

Methods: An online cross-sectional questionnaire was distributed to healthcare professionals via relevant professional organisations in Australia. The questionnaire assessed experience and confidence with genetic testing, glaucoma and genetic knowledge, recommendations for the tests, and factors affecting the decision.

Results: A total of 94 participants completed the questionnaire. The sample was composed of ophthalmologists (36%), optometrists (21%), orthoptists (17%), general practitioners (16%) and clinical geneticists/genetic counsellors (10%). Although familiarity with polygenic risk scores for glaucoma was low overall (11%), the majority reported a positive attitude towards recommending testing based on known risk factors such as family history (91%) and older age (57%). Over 95% indicated that ophthalmologists would be the most appropriate group to order polygenic risk testing and communicate results. The majority felt they would benefit from more training on polygenic risk scores (93%).

Conclusions: Our findings indicated that multiple groups of healthcare professionals were neither familiar nor confident with the concept of glaucoma polygenic risk testing, and identified training and education needs to support the implementation of testing into clinical practice.

背景:青光眼多基因风险测试在临床上的有效实施取决于医护人员对测试的态度和知识。鉴于该测试的新兴应用,它很可能会影响到一系列医护专业人员,并要求所有参与患者护理的人员都能掌握多基因风险评分的概念。据我们所知,这是第一项评估医疗保健专业人员对青光眼多基因测试看法的研究:方法:我们通过澳大利亚的相关专业组织向医护人员发放了一份在线横截面问卷。问卷调查了医护人员在基因检测方面的经验和信心、青光眼和基因知识、对检测的建议以及影响决定的因素:共有 94 名参与者完成了问卷调查。样本中包括眼科医生(36%)、验光师(21%)、视力矫正师(17%)、全科医生(16%)和临床遗传学家/遗传咨询师(10%)。虽然对青光眼多基因风险评分的熟悉程度总体较低(11%),但大多数人表示对根据已知风险因素(如家族史(91%)和年龄较大(57%))建议进行检测持积极态度。超过 95% 的人表示,眼科医生是最适合进行多基因风险检测和通报检测结果的群体。大多数人认为他们将受益于更多有关多基因风险评分的培训(93%):我们的研究结果表明,多类医护专业人员对青光眼多基因风险检测的概念既不熟悉也没有信心,并确定了培训和教育需求,以支持在临床实践中实施检测。
{"title":"Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma.","authors":"Georgina L Hollitt, Miriam C Keane, Thi T Nguyen, Mark M Hassall, Owen M Siggs, Jamie E Craig, Emmanuelle Souzeau","doi":"10.1111/ceo.14438","DOIUrl":"https://doi.org/10.1111/ceo.14438","url":null,"abstract":"<p><strong>Background: </strong>Effective clinical implementation of polygenic risk testing for glaucoma relies on healthcare professionals' attitudes and knowledge of the test. Given the emerging applications of the test, it will likely impact a range of healthcare professionals and will require competency in polygenic risk scores concepts for all those involved in patient care. To our knowledge, this is the first study to assess healthcare professionals' views towards polygenic testing for glaucoma.</p><p><strong>Methods: </strong>An online cross-sectional questionnaire was distributed to healthcare professionals via relevant professional organisations in Australia. The questionnaire assessed experience and confidence with genetic testing, glaucoma and genetic knowledge, recommendations for the tests, and factors affecting the decision.</p><p><strong>Results: </strong>A total of 94 participants completed the questionnaire. The sample was composed of ophthalmologists (36%), optometrists (21%), orthoptists (17%), general practitioners (16%) and clinical geneticists/genetic counsellors (10%). Although familiarity with polygenic risk scores for glaucoma was low overall (11%), the majority reported a positive attitude towards recommending testing based on known risk factors such as family history (91%) and older age (57%). Over 95% indicated that ophthalmologists would be the most appropriate group to order polygenic risk testing and communicate results. The majority felt they would benefit from more training on polygenic risk scores (93%).</p><p><strong>Conclusions: </strong>Our findings indicated that multiple groups of healthcare professionals were neither familiar nor confident with the concept of glaucoma polygenic risk testing, and identified training and education needs to support the implementation of testing into clinical practice.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology and visual outcomes of ocular trauma in the northernmost regions of the Northern Territory. 北领地最北部地区眼外伤的流行病学和视觉后果。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-13 DOI: 10.1111/ceo.14434
Nicholas George Giannopoulos, Danny Lam, Madelaine Moore, Hema Karthik
{"title":"Epidemiology and visual outcomes of ocular trauma in the northernmost regions of the Northern Territory.","authors":"Nicholas George Giannopoulos, Danny Lam, Madelaine Moore, Hema Karthik","doi":"10.1111/ceo.14434","DOIUrl":"https://doi.org/10.1111/ceo.14434","url":null,"abstract":"","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain perception, aqueous humour cytokines, and miosis response following first and second eye femtosecond laser-assisted cataract surgery: A randomised, prospective, intraindividual study. 第一眼和第二眼飞秒激光辅助白内障手术后的痛觉、眼液细胞因子和瞳孔反应:一项随机、前瞻性、个体内研究。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-12 DOI: 10.1111/ceo.14426
Yinhui Yu, Lixia Wang, Yue Qiao, Yang Ye, Yueyang Zhong, Xiaohui Song, Ke Yao, Yibo Yu

Background: To compare pain perception, pupil behaviours, and cytokine levels during first-eye and second-eye femtosecond laser-assisted cataract surgery (FLACS) and determine which is better regarding a short or long interval for bilateral FLACS.

Methods: Notably, 96 eyes of 48 patients with bilateral cataracts underwent the first surgeries in the left or right eye, according to a random sequence. They were further randomised into 2- and 6-week subgroups based on surgery intervals. Pupil size was measured from captured images, and pain perception was assessed using a visual analog scale (VAS). Aqueous humour prostaglandin E2 (PGE2), monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, and IL-8 levels were also quantitatively analysed. All patients were followed for 1 week to evaluate changes in endothelial cell density (ECD), central corneal thickness (CCT), and macular central subfield thickness (CST).

Results: Ocular pain was significantly higher in patients who underwent second-eye FLACS. First tear break-up time was negatively correlated with VAS score. MCP-1 levels were significantly higher in patients who underwent second-eye FLACS, and VAS scores were positively correlated with MCP-1 levels across all patients. There were no differences between sequential FLACS in miosis, PGE2, IL-6, IL-8 levels and changes in postoperative ECD, CCT, and CST. Patients who underwent second-eye FLACS after 6 weeks showed more CCT, CST, and MCP-1 changes than baseline.

Conclusion: Second-eye FLACS causes more pain and upregulated MCP-1. There was no difference between sequential FLACS in PGE2 levels, miosis, and postoperative inflammation. Furthermore, first-eye FLACS triggered a sympathetic irritation, particularly after a 6-week interval.

背景:目的:比较第一眼和第二眼飞秒激光辅助白内障手术(FLACS)过程中的痛觉、瞳孔行为和细胞因子水平,并确定双侧FLACS间隔时间短或长哪个更好:48名双侧白内障患者的96只眼睛按照随机顺序接受了左眼或右眼的首次手术。根据手术间隔,他们被进一步随机分为 2 周和 6 周两组。瞳孔大小通过捕捉到的图像进行测量,疼痛感则通过视觉模拟量表(VAS)进行评估。此外,还定量分析了泪液中前列腺素 E2 (PGE2)、单核细胞趋化蛋白-1 (MCP-1)、白细胞介素 (IL)-6 和 IL-8 的水平。对所有患者进行为期一周的随访,以评估内皮细胞密度(ECD)、角膜中央厚度(CCT)和黄斑中央子场厚度(CST)的变化:结果:接受第二眼FLACS的患者眼部疼痛明显加剧。第一滴泪破裂时间与 VAS 评分呈负相关。第二眼 FLACS 患者的 MCP-1 水平明显更高,所有患者的 VAS 评分与 MCP-1 水平呈正相关。在 miosis、PGE2、IL-6、IL-8 水平以及术后 ECD、CCT 和 CST 的变化方面,连续 FLACS 之间没有差异。6周后接受第二眼FLACS的患者CCT、CST和MCP-1的变化比基线更大:结论:第二眼 FLACS 会导致更多疼痛,并使 MCP-1 上调。在 PGE2 水平、瞳孔缩小和术后炎症方面,连续的 FLACS 之间没有差异。此外,第一眼 FLACS 会引发交感神经刺激,尤其是在间隔 6 周之后。
{"title":"Pain perception, aqueous humour cytokines, and miosis response following first and second eye femtosecond laser-assisted cataract surgery: A randomised, prospective, intraindividual study.","authors":"Yinhui Yu, Lixia Wang, Yue Qiao, Yang Ye, Yueyang Zhong, Xiaohui Song, Ke Yao, Yibo Yu","doi":"10.1111/ceo.14426","DOIUrl":"https://doi.org/10.1111/ceo.14426","url":null,"abstract":"<p><strong>Background: </strong>To compare pain perception, pupil behaviours, and cytokine levels during first-eye and second-eye femtosecond laser-assisted cataract surgery (FLACS) and determine which is better regarding a short or long interval for bilateral FLACS.</p><p><strong>Methods: </strong>Notably, 96 eyes of 48 patients with bilateral cataracts underwent the first surgeries in the left or right eye, according to a random sequence. They were further randomised into 2- and 6-week subgroups based on surgery intervals. Pupil size was measured from captured images, and pain perception was assessed using a visual analog scale (VAS). Aqueous humour prostaglandin E2 (PGE2), monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, and IL-8 levels were also quantitatively analysed. All patients were followed for 1 week to evaluate changes in endothelial cell density (ECD), central corneal thickness (CCT), and macular central subfield thickness (CST).</p><p><strong>Results: </strong>Ocular pain was significantly higher in patients who underwent second-eye FLACS. First tear break-up time was negatively correlated with VAS score. MCP-1 levels were significantly higher in patients who underwent second-eye FLACS, and VAS scores were positively correlated with MCP-1 levels across all patients. There were no differences between sequential FLACS in miosis, PGE2, IL-6, IL-8 levels and changes in postoperative ECD, CCT, and CST. Patients who underwent second-eye FLACS after 6 weeks showed more CCT, CST, and MCP-1 changes than baseline.</p><p><strong>Conclusion: </strong>Second-eye FLACS causes more pain and upregulated MCP-1. There was no difference between sequential FLACS in PGE2 levels, miosis, and postoperative inflammation. Furthermore, first-eye FLACS triggered a sympathetic irritation, particularly after a 6-week interval.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a new vault prediction formula after implantable collamer lens implantation based on factor analysis of multi-modal ophthalmic parameters of anterior and posterior chamber. 基于对前后房多模态眼科参数的因子分析,建立植入式准分子透镜植入术后新穹窿预测公式。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-09 DOI: 10.1111/ceo.14433
Yijia Xu, Fang Liu, Yuhao Ye, Zhe Zhang, Lingling Niu, Peijun Yao, Xiaoying Wang, Xingtao Zhou, Jing Zhao

Background: To establish a novel vault prediction formula after implantable collamer lens (ICL) implantation that considers both anterior and posterior chamber characteristics with multi-modal parameters.

Methods: A total of 103 and 65 eyes were included in the development and validation groups, respectively. Exploratory factor analysis was performed using data from optical coherence tomography and ultrasound biomicroscopy in the development group to synthesise summative factors with different clinical significance. Dominant original metrics with heavy loadings on significant factors (absolute value of the loading coefficient >0.5) were screened for multivariate linear regression models using a stepwise method. The newly derived formula was evaluated and compared to the NK and KS formulas in the validation group.

Results: Six factors (anterior chamber angle, horizontal width, lens, iris, iridociliary complex and ciliary body) were generated after dimension reduction via factor analysis. Factors 2 (horizontal width), 3 (lens), and 5 (iridociliary complex) had a significant influence on the vault. When dominant metrics on these factors were screened for further model building, ICL size, anterior chamber width, crystalline lens rise, iris curvature, and iris-ciliary process distance were retained in the final formula, with an adjusted R2 of 0.698, a median absolute error of 81.97 mm, and a root-mean-square error of 103.35 mm.

Conclusions: Multiple intraocular components, including the lens, iris, and ciliary body, play important roles in vault determination. The new formula exhibits good accuracy for vault predictions and ICL size recommendations.

背景:建立一种新型的植入式有晶体眼人工晶体(ICL)术后穹窿预测公式:建立一种新型穹窿预测公式,通过多模态参数同时考虑植入式有晶体眼(ICL)的前房和后房特征:开发组和验证组分别包括 103 只和 65 只眼睛。利用开发组的光学相干断层扫描和超声生物显微镜数据进行探索性因子分析,归纳出具有不同临床意义的总结性因子。采用逐步法筛选出在重要因子上有较高载荷的主要原始指标(载荷系数绝对值大于 0.5),用于多变量线性回归模型。在验证组中对新得出的公式进行评估,并与 NK 和 KS 公式进行比较:结果:通过因子分析缩减尺寸后产生了六个因子(前房角、水平宽度、晶状体、虹膜、虹膜睫状体复合体和睫状体)。因素 2(水平宽度)、3(晶状体)和 5(虹膜睫状体复合体)对穹窿有显著影响。在筛选这些因素的主要指标以进一步建立模型时,ICL尺寸、前房宽度、晶状体上升、虹膜曲率和虹膜睫状体距离被保留在最终公式中,调整后的R2为0.698,中位绝对误差为81.97毫米,均方根误差为103.35毫米:结论:包括晶状体、虹膜和睫状体在内的多种眼内成分在穹窿测定中起着重要作用。新公式在预测穹窿和推荐 ICL 大小方面表现出良好的准确性。
{"title":"Establishment of a new vault prediction formula after implantable collamer lens implantation based on factor analysis of multi-modal ophthalmic parameters of anterior and posterior chamber.","authors":"Yijia Xu, Fang Liu, Yuhao Ye, Zhe Zhang, Lingling Niu, Peijun Yao, Xiaoying Wang, Xingtao Zhou, Jing Zhao","doi":"10.1111/ceo.14433","DOIUrl":"https://doi.org/10.1111/ceo.14433","url":null,"abstract":"<p><strong>Background: </strong>To establish a novel vault prediction formula after implantable collamer lens (ICL) implantation that considers both anterior and posterior chamber characteristics with multi-modal parameters.</p><p><strong>Methods: </strong>A total of 103 and 65 eyes were included in the development and validation groups, respectively. Exploratory factor analysis was performed using data from optical coherence tomography and ultrasound biomicroscopy in the development group to synthesise summative factors with different clinical significance. Dominant original metrics with heavy loadings on significant factors (absolute value of the loading coefficient >0.5) were screened for multivariate linear regression models using a stepwise method. The newly derived formula was evaluated and compared to the NK and KS formulas in the validation group.</p><p><strong>Results: </strong>Six factors (anterior chamber angle, horizontal width, lens, iris, iridociliary complex and ciliary body) were generated after dimension reduction via factor analysis. Factors 2 (horizontal width), 3 (lens), and 5 (iridociliary complex) had a significant influence on the vault. When dominant metrics on these factors were screened for further model building, ICL size, anterior chamber width, crystalline lens rise, iris curvature, and iris-ciliary process distance were retained in the final formula, with an adjusted R<sup>2</sup> of 0.698, a median absolute error of 81.97 mm, and a root-mean-square error of 103.35 mm.</p><p><strong>Conclusions: </strong>Multiple intraocular components, including the lens, iris, and ciliary body, play important roles in vault determination. The new formula exhibits good accuracy for vault predictions and ICL size recommendations.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary intraocular lenses: Reversing to move forward 二次眼内透镜:逆转前进。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-07 DOI: 10.1111/ceo.14414
Adrian T. Fung MMed, FRANZCO
{"title":"Secondary intraocular lenses: Reversing to move forward","authors":"Adrian T. Fung MMed, FRANZCO","doi":"10.1111/ceo.14414","DOIUrl":"10.1111/ceo.14414","url":null,"abstract":"","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The enigma of corneal astigmatism 角膜散光之谜。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-07 DOI: 10.1111/ceo.14419
Mohammed Ziaei MD, FRCOphth
{"title":"The enigma of corneal astigmatism","authors":"Mohammed Ziaei MD, FRCOphth","doi":"10.1111/ceo.14419","DOIUrl":"10.1111/ceo.14419","url":null,"abstract":"","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuing Professional Development 持续专业发展
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-07 DOI: 10.1111/ceo.14417
{"title":"Continuing Professional Development","authors":"","doi":"10.1111/ceo.14417","DOIUrl":"10.1111/ceo.14417","url":null,"abstract":"","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141936845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anisometropia and its correction in children in northwest China: A study based on autorefraction data. 中国西北地区儿童的斜视及其矫正:基于自动屈光数据的研究。
IF 4.9 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-08-06 DOI: 10.1111/ceo.14430
Qian Yao, Junhan Wei, Lu Ye, Xianyi Duan, Meixia Ren, Jie Min, Pei Cheng, Guoyun Zhang

Background: To investigate the prevalence and correction of anisometropia among primary school children in northwestern China.

Methods: A cross-sectional school-based study was conducted in Shaanxi Province. Visual acuity (VA) and autorefraction without cycloplegia were assessed in all participants, and some received axial length (AL) measurements. Anisometropia was categorised based on spherical equivalent (SE), cylindrical (CYL), and AL. The prevalence of anisometropia and refractive correction across different ages and sexes, and correlations between ocular parameters, were analysed.

Results: The study included 29 153 children aged 6-12 (mean age 9.52 ± 1.73 years) for VA and autorefraction measurements, and 1176 children for AL measurements. The prevalence of myopia (SE ≤ -0.50 D), hyperopia (SE ≥ +0.50 D), and anisometropia (interocular SE difference ≥1.00 D) was 65.26%, 15.09%, and 16.50%, respectively. Anisometropia severity, based on SE (χ2 = 443.758, p < 0.001), CYL (χ2 = 41.669, p < 0.001), and AL (χ2 = 95.505, p < 0.001), increased with age, with no significant differences between sexes. Interocular SE difference correlated with interocular spherical power (r = 0.806, p < 0.001), CYL (r = 0.21, p < 0.001), and AL (r = 0.365, p < 0.001). Additionally, interocular CYL difference was positively correlated with interocular AL difference (r = 0.16, p < 0.001). Despite the high prevalence of anisometropia, less than 30% of affected children received refractive correction.

Conclusions: Anisometropia of SE, CYL, and AL increased progressively with age. Despite the elevated prevalence of anisometropia, the utilisation of refractive correction remained strikingly low.

背景:调查中国西北地区小学生近视的发生率和矫正情况:调查中国西北地区小学生近视的发生率和矫正情况:在陕西省开展了一项横断面校本研究。所有参与者均接受了视力(VA)和无回旋屈光度的自动屈光度评估,部分参与者还接受了轴长(AL)测量。根据球面等效视力(SE)、圆柱视力(CYL)和轴向长度(AL)对斜视进行分类。研究分析了不同年龄和性别儿童的斜视患病率和屈光矫正情况,以及眼部参数之间的相关性:研究共对 29 153 名 6-12 岁儿童(平均年龄为 9.52 ± 1.73 岁)进行了视力和自动屈光度测量,对 1176 名儿童进行了屈光度测量。近视(SE ≤ -0.50 D)、远视(SE ≥ +0.50 D)和异视(眼间 SE 差≥1.00 D)的发生率分别为 65.26%、15.09% 和 16.50%。基于 SE 的斜视严重程度(χ2 = 443.758,P 2 = 41.669,P 2 = 95.505,P 结论:随着年龄的增长,SE、CYL 和 AL 的斜视度数逐渐增加。尽管近视的发生率很高,但屈光矫正的使用率却很低。
{"title":"Anisometropia and its correction in children in northwest China: A study based on autorefraction data.","authors":"Qian Yao, Junhan Wei, Lu Ye, Xianyi Duan, Meixia Ren, Jie Min, Pei Cheng, Guoyun Zhang","doi":"10.1111/ceo.14430","DOIUrl":"https://doi.org/10.1111/ceo.14430","url":null,"abstract":"<p><strong>Background: </strong>To investigate the prevalence and correction of anisometropia among primary school children in northwestern China.</p><p><strong>Methods: </strong>A cross-sectional school-based study was conducted in Shaanxi Province. Visual acuity (VA) and autorefraction without cycloplegia were assessed in all participants, and some received axial length (AL) measurements. Anisometropia was categorised based on spherical equivalent (SE), cylindrical (CYL), and AL. The prevalence of anisometropia and refractive correction across different ages and sexes, and correlations between ocular parameters, were analysed.</p><p><strong>Results: </strong>The study included 29 153 children aged 6-12 (mean age 9.52 ± 1.73 years) for VA and autorefraction measurements, and 1176 children for AL measurements. The prevalence of myopia (SE ≤ -0.50 D), hyperopia (SE ≥ +0.50 D), and anisometropia (interocular SE difference ≥1.00 D) was 65.26%, 15.09%, and 16.50%, respectively. Anisometropia severity, based on SE (χ<sup>2</sup> = 443.758, p < 0.001), CYL (χ<sup>2</sup> = 41.669, p < 0.001), and AL (χ<sup>2</sup> = 95.505, p < 0.001), increased with age, with no significant differences between sexes. Interocular SE difference correlated with interocular spherical power (r = 0.806, p < 0.001), CYL (r = 0.21, p < 0.001), and AL (r = 0.365, p < 0.001). Additionally, interocular CYL difference was positively correlated with interocular AL difference (r = 0.16, p < 0.001). Despite the high prevalence of anisometropia, less than 30% of affected children received refractive correction.</p><p><strong>Conclusions: </strong>Anisometropia of SE, CYL, and AL increased progressively with age. Despite the elevated prevalence of anisometropia, the utilisation of refractive correction remained strikingly low.</p>","PeriodicalId":55253,"journal":{"name":"Clinical and Experimental Ophthalmology","volume":null,"pages":null},"PeriodicalIF":4.9,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Experimental Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1